EMILIA Results Are In , Good News !!

[phil]

Genentech issued a Press release yesterday , announcing that EMILIA's results show that Herceptin T DM-1 significantly out -performs Tykerb/ Xeloda in terms of PFS, OS pending. We Survivors/ Caregivers also know it will ven more significantly out-perform Tykerb/ Xel. in terms of QOL. We are not surprised, nor are Research Oncologists . The only ones " surprised " are Dr. Pazdur and his T DM-1 " advisors " at This FDA !
At the end of the Press Release , Gen. mentions that they have THIRTY " conjugates " in the pipeline ! Conjugates are genetic drugs with chemo directly attached . T DM-1 is the only one out there right now, but imagine if even a few others come out over the next few yrs !
The down-side is that Gen.'s press release says it will file an application with This FDA " later this yr. " ( Summer ?) . Then This FDA typically will take 6 months to make a decision, which brings us to 2013 !! And Dr. Pazdur , who has been obstinately blocking the drug for 19 months, will make an " im-partial ", " rational " decision ? We think not ! So, that is why we have been callling for HHS to Investigate This FDA , and will continue to speak out. Sign our HHS Petition at signon.org " FDA Blocks Life Saving Drug ". Pass It On !